Current advances in pharmacovigilance in the USA and Europe: meeting the challenges of safety monitoring in HIV.

Purpose of reviewThe success of antiretroviral therapy in HIV disease comes currently with the realization that patients are committed to life-long treatment, which raises the possibility of long-term toxicity. Such long-term side effects may not be identified in initial clinical trials requiring, t